Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
The CRISPR segment is estimated to grow at the highest CAGR during the forecast period.
Market Analysis and Insights: Global Genome Editing/Genome Engineering Market
In 2019, the global Genome Editing/Genome Engineering market size was US$ 3291.6 million and it is expected to reach US$ 6166.3 million by the end of 2026, with a CAGR of 9.3% during 2021-2026.
Global Genome Editing/Genome Engineering Scope and Market Size
Genome Editing/Genome Engineering market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genome Editing/Genome Engineering market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Genome Editing/Genome Engineering market is segmented into CRISPR, TALEN, ZFN, etc.
Segment by Application, the Genome Editing/Genome Engineering market is segmented into Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, etc.
Regional and Country-level Analysis
The Genome Editing/Genome Engineering market is analysed and market size information is provided by regions (countries).
The key regions covered in the Genome Editing/Genome Engineering market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Genome Editing/Genome Engineering market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Genome Editing/Genome Engineering business, the date to enter into the Genome Editing/Genome Engineering market, Genome Editing/Genome Engineering product introduction, recent developments, etc.
The major vendors include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated Dna Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, Crispr Therapeutics, etc.
This report focuses on the global Genome Editing/Genome Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genome Editing/Genome Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated Dna Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
CRISPR
TALEN
ZFN
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Genome Editing/Genome Engineering status, future forecast, growth opportunity, key market and key players.
To present the Genome Editing/Genome Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Genome Editing/Genome Engineering are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The CRISPR segment is estimated to grow at the highest CAGR during the forecast period.
Market Analysis and Insights: Global Genome Editing/Genome Engineering Market
In 2019, the global Genome Editing/Genome Engineering market size was US$ 3291.6 million and it is expected to reach US$ 6166.3 million by the end of 2026, with a CAGR of 9.3% during 2021-2026.
Global Genome Editing/Genome Engineering Scope and Market Size
Genome Editing/Genome Engineering market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genome Editing/Genome Engineering market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Genome Editing/Genome Engineering market is segmented into CRISPR, TALEN, ZFN, etc.
Segment by Application, the Genome Editing/Genome Engineering market is segmented into Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, etc.
Regional and Country-level Analysis
The Genome Editing/Genome Engineering market is analysed and market size information is provided by regions (countries).
The key regions covered in the Genome Editing/Genome Engineering market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Genome Editing/Genome Engineering Market Share AnalysisGenome Editing/Genome Engineering market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Genome Editing/Genome Engineering business, the date to enter into the Genome Editing/Genome Engineering market, Genome Editing/Genome Engineering product introduction, recent developments, etc.
The major vendors include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated Dna Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, Crispr Therapeutics, etc.
This report focuses on the global Genome Editing/Genome Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genome Editing/Genome Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated Dna Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Market segment by Type, the product can be split into
CRISPR
TALEN
ZFN
Market segment by Application, split into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Genome Editing/Genome Engineering status, future forecast, growth opportunity, key market and key players.
To present the Genome Editing/Genome Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Genome Editing/Genome Engineering are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
